Genomic Testing for Treatment Decision in Chemotherapy for Patients with Early Breast Cancer for Premenopausal Patients and for Patients Suitable for the ADAPT Protocol | Tenderlake

Genomic Testing for Treatment Decision in Chemotherapy for Patients with Early Breast Cancer for Premenopausal Patients and for Patients Suitable for the ADAPT Protocol

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
30 December 2025
Closing Date:
13 January 2026
Location(s):
SI032 Podravska (SI Slovenia/SLOVENIJA)
Description:
Provision of genomic testing services for treatment decision in chemotherapy for premenopausal patients with early breast cancer and those suitable for the ADAPT protocol.

The subject of the public procurement is the provision of services: Genomic testing for treatment decision in chemotherapy for patients with early breast cancer for premenopausal patients and for patients suitable for the ADAPT protocol.


LOT-0000
Genomic testing for treatment decision in chemotherapy for patients with early breast cancer for premenopausal patients and for patients suitable for the ADAPT protocol.
The subject of the public procurement is the provision of services: Genomic testing for treatment decision in chemotherapy for patients with early breast cancer for premenopausal patients and for patients suitable for the ADAPT protocol.

The Buyer:
UNIVERZITETNI KLINIČNI CENTER MARIBOR
Additional information:
Link:
View Full Notice
Link:
Additional document: DocLot0
Link:
Download Full Notice as PDF
CPV Code(s):
85145000 - Services provided by medical laboratories